These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 56749)

  • 21. [Prophylaxis of urinary tract infections in rats by long-term chemotherapy].
    Prát V; Konícková L; Ritzerfeld W; Losse H
    Int Z Klin Pharmakol Ther Toxikol; 1969 Jan; 2(1):26-9. PubMed ID: 4894945
    [No Abstract]   [Full Text] [Related]  

  • 22. [Actual aspects of pulmonary treatment in cystic fibrosis (author's transl)].
    Kraemer R; Stoll E; Rossi E
    Schweiz Rundsch Med Prax; 1978 Jun; 67(24):906-9. PubMed ID: 351606
    [No Abstract]   [Full Text] [Related]  

  • 23. [Importance of animal experiments for antibcterial therapy of infection of the urinary tract in man].
    Prát V; Konícková L
    Cas Lek Cesk; 1971 Sep; 110(39):909-13. PubMed ID: 5098273
    [No Abstract]   [Full Text] [Related]  

  • 24. [Susceptibility to nitrofurantoin, biseptol and nalidixic acid of E. coli strains isolated from urine in the years 1983-1990].
    Jasińska B; Szeniawska A; Mazur E; Fota-Markowska H; Ligeza J; Kunkiewicz A; Niedźwiadek J
    Ann Univ Mariae Curie Sklodowska Med; 1992; 47():133-6. PubMed ID: 1365784
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Faecal and periurethral flora after oral administration of sulphonamide, nitrofurantoin and nalidixic acid.
    Lincoln K; Lidin-Janson G; Winberg J
    Acta Paediatr Scand; 1972 Nov; 61(6):643-7. PubMed ID: 4562786
    [No Abstract]   [Full Text] [Related]  

  • 26. [Effects and side-effects of ampicillin versus ciclacillin in a double blind randomized trial (author's transl)].
    Rüefli P
    Schweiz Rundsch Med Prax; 1976 Sep; 65(37):1130-4. PubMed ID: 794863
    [No Abstract]   [Full Text] [Related]  

  • 27. [Inhibitory action of nitrofurantoin on the bacteriostatic power in vitro of nalidixic acid].
    Piguet JD
    Ann Inst Pasteur (Paris); 1969 Jan; 116(1):43-8. PubMed ID: 4890584
    [No Abstract]   [Full Text] [Related]  

  • 28. [Experiences with the semisynthetic cephalosporin antibiotic agent cephalothin].
    Mössner G; Stieler U; Laar HJ
    Munch Med Wochenschr; 1967 Feb; 109(6):301-8. PubMed ID: 4385783
    [No Abstract]   [Full Text] [Related]  

  • 29. [Clinical aspects and therapy of septic shock with urogenital etiology].
    Molnár I; Gyarmathy F; Kondás J
    Z Urol Nephrol; 1974 Jul; 67(7):543-7. PubMed ID: 4155195
    [No Abstract]   [Full Text] [Related]  

  • 30. [Cefotaxime in septicaemia and severe infections due to multiresistant Gram-negative bacilli (author's transl)].
    Dureux JB; Canton P; Roche G; Weber M; Gérard A
    Nouv Presse Med; 1981 Feb; 10(8):601-6. PubMed ID: 6259602
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Drugs in shock treatment].
    Dietzman RH; Motsay GJ; Lillehei RC
    Internist (Berl); 1971 Mar; 12(3):103-7. PubMed ID: 4927712
    [No Abstract]   [Full Text] [Related]  

  • 32. Urinary antiseptics.
    Ceylon Med J; 1971 Mar; 16(1):57-60. PubMed ID: 5128721
    [No Abstract]   [Full Text] [Related]  

  • 33. [Chemotherapy of the urinary tract infections caused by Providencia in postoperatively irradiated bladder carcinoma].
    Schmitt G; Neussel H
    Med Monatsschr; 1970 Oct; 24(10):462-5. PubMed ID: 5474347
    [No Abstract]   [Full Text] [Related]  

  • 34. [Drug therapy of chronic urinary tract infections].
    Haschek H
    Med Welt; 1972 Oct; 23(42):1473-5. PubMed ID: 4636868
    [No Abstract]   [Full Text] [Related]  

  • 35. [Therapy of acute urinary tract infections. Short communication].
    Weissenbacher G
    Padiatr Padol; 1973; 8(1):100-1. PubMed ID: 4788343
    [No Abstract]   [Full Text] [Related]  

  • 36. Some aspects of the treatment of shock in animals.
    Jenkins WL
    J S Afr Vet Assoc; 1972 Jun; 43(2):163-8. PubMed ID: 4680372
    [No Abstract]   [Full Text] [Related]  

  • 37. [Various clinical and experimental problems in the therapy of urinary tract infections].
    Prát V; Konícková L
    Cas Lek Cesk; 1970 Sep; 109(39):915-22. PubMed ID: 5507020
    [No Abstract]   [Full Text] [Related]  

  • 38. Intravenous nalidixic acid in urogenital sepsis: report of 25 courses.
    Zinsser HH; Doenecke AL
    J Urol; 1970 Apr; 103(4):476-9. PubMed ID: 4314486
    [No Abstract]   [Full Text] [Related]  

  • 39. [Clinical evaluation of mezlocillin in the treatment of urinary and respiratory tract infections].
    Polubiec A; Starzyńska R; Kubica I
    Pol Tyg Lek; 1982 Jul; 37(21):617-8. PubMed ID: 6216466
    [No Abstract]   [Full Text] [Related]  

  • 40. [Carbenicillin. Current data on its use].
    Bertoye A; Woehrle R
    Lyon Med; 1971; 225():Suppl:137-41. PubMed ID: 5564793
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.